J
Julio A. Panza
Researcher at New York Medical College
Publications - 263
Citations - 22872
Julio A. Panza is an academic researcher from New York Medical College. The author has contributed to research in topics: Coronary artery disease & Endothelium. The author has an hindex of 78, co-authored 254 publications receiving 21465 citations. Previous affiliations of Julio A. Panza include Catholic University of the Sacred Heart & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.
TL;DR: Endothelium-mediated vasodilation is impaired in patients with essential hypertension and this defect may play an important part in the functional abnormalities of resistance vessels that are observed in hypertensive patients.
Journal ArticleDOI
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
Robert O. Bonow,Gerald Maurer,Kerry L. Lee,Thomas A. Holly,Philip F. Binkley,Patrice Desvigne-Nickens,Jarosław Drożdż,Pedro Silvio Farsky,Arthur M. Feldman,Torsten Doenst,Robert E. Michler,Daniel S. Berman,Jose C. Nicolau,Patricia A. Pellikka,Krzysztof Wróbel,Nasri Alotti,Federico M. Asch,Liliana E. Favaloro,Lilin She,Eric J. Velazquez,Robert H. Jones,Julio A. Panza +21 more
TL;DR: The presence of viable myocardium was associated with a greater likelihood of survival in patients with coronary artery disease and left ventricular dysfunction, but this relationship was not significant after adjustment for other baseline variables.
Journal ArticleDOI
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.
TL;DR: It is indicated that patients with essential hypertension have a defect in the endothelium-derived nitric oxide system that may at least partly account for both the increased vascular resistance under basal conditions and the impaired response to endothelia-dependent vasodilators.
Journal ArticleDOI
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Eric J. Velazquez,Kerry L. Lee,Robert H. Jones,Hussein R. Al-Khalidi,James A. Hill,Julio A. Panza,Robert E. Michler,Robert O. Bonow,Torsten Doenst,Mark C. Petrie,Jae K. Oh,Lilin She,Vanessa L. Moore,Patrice Desvigne-Nickens,George Sopko,Jean L. Rouleau +15 more
TL;DR: In a cohort of patients with ischemic cardiomyopathy, the rates of death from any cause, death from cardiovascular causes, and death fromAny cause or hospitalization for cardiovascular causes were significantly lower over 10 years among patients who underwent CABG in addition to receiving medical therapy than among those who received medical therapy alone.
Journal ArticleDOI
Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity
TL;DR: To determine whether there are circadian variations in vascular tone and to investigate their underlying mechanisms, blood flow and vascular resistance in the forearm are measured and their responses to phentolamine and sodium nitroprusside are measured.